Literature DB >> 3066846

The 150th anniversary of the first depiction of the lesions of multiple sclerosis.

A Compston1.   

Abstract

The clinical and pathological features of multiple sclerosis were fully described, in France and subsequently in England, during the latter half of the XIXth century but clinical descriptions, personal accounts and depictions of the disease had appeared at various times over the previous 50 years. Jean Cruveilhier is usually credited with having first illustrated the lesions of multiple sclerosis in the second tome of his pathological atlas which bears the title date 1835. But the 40 livraisons which make up this work were published separately in parts and documentary evidence contained within the second volume indicates that the putative case of multiple sclerosis cannot have appeared earlier than 1841. Robert Carswell also may have published his pathological atlas in parts but the work was completed by 1838 and so his depiction of the lesions of multiple sclerosis, appearing on plate 4 fig 1, predates Cruveilhier's by at least three years. Curiously, Carswell and Cruveilhier each observed their pathological material in Paris but they cannot have depicted the same individual. 1988 is therefore the 150th anniversary of the depiction of the lesions of multiple sclerosis; the unnamed patient was French, the illustrator a Scotsman.

Entities:  

Mesh:

Year:  1988        PMID: 3066846      PMCID: PMC1032909          DOI: 10.1136/jnnp.51.10.1249

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  Reviewing multiple sclerosis.

Authors:  A Compston
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

Review 2.  Multiple sclerosis and the role of immune cells.

Authors:  Rune A Høglund; Azzam A Maghazachi
Journal:  World J Exp Med       Date:  2014-08-20

3.  The dynamics of multiple sclerosis. The Charcot Lecture.

Authors:  W I McDonald
Journal:  J Neurol       Date:  1993-01       Impact factor: 4.849

Review 4.  Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.

Authors:  Itay Raphael; Johanna Webb; Olaf Stuve; William Haskins; Thomas Forsthuber
Journal:  Expert Rev Clin Immunol       Date:  2014-12-18       Impact factor: 4.473

5.  In search of a conceptualization of multiple sclerosis: a historical perspective.

Authors:  Michelle A Butler; Thomas L Bennett
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

Review 6.  Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms.

Authors:  Aikaterini Christogianni; Richard Bibb; Scott L Davis; Ollie Jay; Michael Barnett; Nikos Evangelou; Davide Filingeri
Journal:  Temperature (Austin)       Date:  2018-09-05

7.  Heine's illness: the case for multiple sclerosis.

Authors:  E H Jellinek
Journal:  J R Soc Med       Date:  1990-08       Impact factor: 18.000

8.  Fingolimod: The first oral drug approved by food and drug administration; A breakthrough in treatment of multiple sclerosis.

Authors:  Manish Singh; Goutham Cugati; Pratibha Singh; Ajai Kumar Singh
Journal:  J Pharm Bioallied Sci       Date:  2011-07

Review 9.  What went wrong? The flawed concept of cerebrospinal venous insufficiency.

Authors:  José M Valdueza; Florian Doepp; Stephan J Schreiber; Bob W van Oosten; Klaus Schmierer; Friedemann Paul; Mike P Wattjes
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-27       Impact factor: 6.200

10.  Interactions between neutrophils, Th17 cells, and chemokines during the initiation of experimental model of multiple sclerosis.

Authors:  Dagmara Weronika Wojkowska; Piotr Szpakowski; Dominika Ksiazek-Winiarek; Marcin Leszczynski; Andrzej Glabinski
Journal:  Mediators Inflamm       Date:  2014-02-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.